INTEGRATED BIOPHARMA INC Tax Adjustments, Settlements, and Unusual Provisions
INTEGRATED BIOPHARMA INC (INBP) reported Tax Adjustments, Settlements, and Unusual Provisions of $202.00 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2019-08-29.
Discontinued › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2019-08-29
- INTEGRATED BIOPHARMA INC tax adjustments, settlements, and unusual provisions for the quarter ending 2018-06-30 was -$48.00K.
- INTEGRATED BIOPHARMA INC tax adjustments, settlements, and unusual provisions for the quarter ending 2018-03-31 was $0.00.
- INTEGRATED BIOPHARMA INC tax adjustments, settlements, and unusual provisions for the quarter ending 2017-12-31 was $250.00K.
- INTEGRATED BIOPHARMA INC tax adjustments, settlements, and unusual provisions for the quarter ending 2017-09-30 was $0.00.
- INTEGRATED BIOPHARMA INC tax adjustments, settlements, and unusual provisions for fiscal 2019 was $202.00K, a 0.00% change from fiscal 2018.
- INTEGRATED BIOPHARMA INC tax adjustments, settlements, and unusual provisions for fiscal 2018 was $202.00K.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 3 month | Tax Adjustments, Settlements, and Unusual Provisions 6 month | Tax Adjustments, Settlements, and Unusual Provisions 9 month | Tax Adjustments, Settlements, and Unusual Provisions 12 month |
|---|---|---|---|---|
| 2019-06-30 | $202.00K 10-K · filed 2019-08-29 | |||
| 2018-06-30 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | -$48.00K derived: sum of 2 quarters · filed 2018-09-12 | $202.00K derived: sum of 3 quarters · filed 2018-09-12 | $202.00K 10-K · filed 2018-09-12 |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $250.00K derived: sum of 2 quarters · filed 2018-05-09 | $250.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $250.00K 10-Q · filed 2018-02-09 | $250.00K 10-Q · filed 2018-02-09 | ||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2018-09-12 |